September 2020: New results are being finalised from the CASP platform for patient-specific data obtained from our clinical partner, the Wythenshawe Hospital in the south of Manchester.

 

June 2020: In light of COVID-19 restrictions in the UK, the CASP team operate as normal but working remotely from home.

 

March 2020: The initial results from the CASP platform are presented at at the opening of the new state-of-the-art Magnetic Resonance Centre (MCMR) at The University of Manchester funded by British Heart Foundation.

1605713239116.jpg

January 2020: Charlie Bright joins the CASP team as a new PhD student, developing the CASP platform over the next 3 years, incorporating new features and testing the codes on new patient-specific data.

October 2019: A new PhD funding is awarded to the CASP team to recruit for a new position within the company. The funding is provided by the Department of MACE at the University of Manchester.

 

September 2019: Dr Amir Keshmiri presenting further findings from the CASP platform at the annual conference of the European Society of Artificial Organs https://www.esao.org/.

 

June 2019: Dr Amir Keshmiri and his team presenting the preliminary results of CASP at the 6th International Conference on Computational and Mathematical Biomedical Engineering (CMBE2019) held between 10-12 June 2019 in Japan. 

1607083583105.jpg

May 2019: CASP being invited to the Affordable Health Technology workshop in Brazil to explore the potential of CASP in Latin America (https://affordablehealthtech.com/).

February 2019: The Engineering and Physical Sciences Research Council (EPSRC) provide the team with a boost of £50,000 as part of the Impact Accelerator Account award.

publicity_graft.jpg

February 2019: The Engineering and Physical Sciences Research Council (EPSRC) provide the team with a boost of £50,000 as part of the Impact Accelerator Account award.

 

November 2018: CASP wins a place on the North of England Life Science Accelerator programme at BioCity, Alderly Park.

 

April 2018: The team are awarded £151,000 by the Medical Research Council (MRC).

 

July 2018: The team develop the first concept of CASP.

November 2016: The team gains media attention after proposing a novel bypass graft design for treating cardiovascular disease in the scientific journal, PLOS One. For further details, visit HeliRidgeGraft.com.

 

January 2015: The research team in Manchester are awarded £125,000 by the Engineering and Physical Sciences Research Council (EPSRC) to develop a novel bypass graft using computational fluid dynamics optimisation algorithms.